Accenture Ventures Makes Strategic Investment in Turbine

May 17, 2024

Accenture, through Accenture Ventures, made a strategic growth investment in Turbine, a Budapest-based company that builds AI-driven predictive simulation software for interpreting human biology to accelerate drug discovery. The investment will help Turbine expand its platform to global biopharma clients and integrate its Simulated Cell technology into larger drug-development workflows; terms were not disclosed.

Buyers
Accenture (Accenture Ventures)
Targets
Turbine
Industry
Biotechnology
Location
Budapest, Hungary
Transaction Type
Growth capital

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.